Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHONY.L Regulatory News (HONY)

  • There is currently no data for HONY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of General Meeting

1 Jun 2022 16:10

RNS Number : 6321N
Honeycomb Investment Trust PLC
01 June 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, ANY OFFER, INVITATION OR RECOMMENDATION TO PURCHASE, SELL OR SUBSCRIBE FOR ANY SECURITIES IN ANY JURISDICTION AND NEITHER THE ISSUE OF THE INFORMATION NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, ANY INVESTMENT ACTIVITY

 

FOR IMMEDIATE RELEASE

1 June 2022

Honeycomb Investment Trust plc ("Honeycomb")

Results of General Meeting

Further to the circular published by Honeycomb on 10 May 2022 (the "Circular") and made available on Honeycomb's website at www.honeycombplc.com, Honeycomb is pleased to announce that, at the General Meeting held today to approve the proposed combination with Pollen Street Capital Holdings Limited ("Pollen Street") (the "Combination"), all resolutions proposed and set out in the Notice of General Meeting in connection with the approval and resultant implementation of the Combination were voted on by a poll and duly approved by a strong majority of Shareholders.

The total number of votes received on each resolution put to the General Meeting was as follows:

No.

Resolution

For

Against

Votes Withheld

Votes

%

Votes

%

1.

To approve the Combination on the terms set out in the Share Purchase Agreement and to grant the Honeycomb Directors the authority to take such steps as are necessary or appropriate to implement the Combination.

26,463,342

85.31

4,557,297

 

14.69

63,355

 

2.

To permit the Board to issue the Consideration Shares to the Pollen Street Shareholders in connection with the Combination.

26,463,092

85.31

4,557,547

14.69

 

63,355

 

3.

To approve the Combined Group Investment Policy, the New Remuneration Policy, the LTIP and the DBP.

23,374,180

 

82.41

 

4,987,730

17.59

 

2,722,084

4.

To approve the increase to the Directors' Fee Cap

21,548,920

 

82.87

 

4,452,824

 

17.13

 

5,082,250

 

5.

To approve the waiver of any requirement under Rule 9 of the Takeover Code for the Concert Parties to make a general offer to Shareholders for the Honeycomb Shares as a result of: (a) the issue of Consideration Shares to the Concert Parties; and (b) the carrying out of any share buyback by Honeycomb pursuant to the Existing Buyback Authority.

20,760,626

 

80.10

 

5,158,250

 

19.90

 

4,340,980

 

6.

To approve the Related Party Transactions.

21,361,404

 

82.42

 

4,557,472

 

17.58

 

4,340,980

 

 

The number of Honeycomb Shares in issue as at the Voting Record Time of 6.30 p.m. (London time) on 30 May 2022 was 39,449,919. Honeycomb holds 4,487,485 shares in treasury. Therefore, the total number of voting rights in Honeycomb at the Voting Record Time was 34,962,434.

In accordance with Listing Rules 9.6.2R and 9.6.3R, the full text of the resolutions passed at the General Meeting will be submitted to the National Storage Mechanism and will be available for inspection in due course at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Capitalised terms used in this announcement but not otherwise defined shall have the meaning given to them in the Circular.

Enquiries:

Cenkos - Financial Adviser, Sponsor and Joint Broker to Honeycomb

Tunga Chigovanyika

Daniel BalabanoffJustin Zawoda Martin

+44 20 7397 8900

 

BofA Securities - Financial Adviser to Honeycomb Arif VohraGeoff Iles

Oliver Elias+44 20 7628 1000

Liberum - Joint Broker

Chris Clarke

+44 20 3100 2000

 

Finsbury Glover Hering - Communications Adviser

Michael Turner

Chris Sibbald

+44 20 7251 3801

 

About Honeycomb

Honeycomb is a UK-listed closed ended investment trust dedicated to providing investors with access to asset backed lending opportunities, with potential to generate high income returns, together with strong capital preservation.

About Pollen Street

Pollen Street was founded in 2013 and is an independent, alternative investment management company dedicated to investing in the financial and business services sectors. Pollen Street has extensive experience investing in both credit and private equity strategies and has a strong and consistent track record of delivering top tier returns. A wholly owned subsidiary of Pollen Street serves as Honeycomb's investment manager.

Additional information

Cenkos Securities plc ("Cenkos"), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively as sponsor for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither Cenkos, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos in connection with this announcement, the Circular, or any statement contained herein or otherwise.

Merrill Lynch International ("BofA Securities"), which is authorised by the Prudential Regulation Authority ("PRA") and regulated by the FCA and the PRA in the United Kingdom, is acting as financial adviser exclusively for Honeycomb and for no one else and will not be responsible to anyone other than Honeycomb for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement. Neither BofA Securities, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of BofA Securities in connection with this announcement, the Circular, or any statement contained herein or otherwise.

Liberum Capital Limited ("Liberum") is authorised and regulated in the United Kingdom by the FCA and is acting exclusively for Honeycomb and no-one else in connection with the proposed Combination and will not be responsible to anyone other than the Honeycomb for providing the protections afforded to the clients of Liberum, as applicable, or for affording advice in relation to the contents of the announcement, the Circular, or any matters referred to therein. Nothing in this paragraph shall serve to exclude or limit any responsibilities Liberum may have under the Financial Services and Markets Act 2000 or the regulatory regime established thereunder.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMEFLFBLQLBBBK
Date   Source Headline
21st Aug 20177:00 amRNSNet Asset Value - July 2017
21st Aug 20177:00 amRNSMonthly Update - July 2017
18th Aug 20177:00 amRNSHolding(s) in Company - TR-1 Notification
21st Jul 20177:00 amRNSNet Asset Value - June 2017
21st Jul 20177:00 amRNSMonthly Update - June 2017
21st Jun 20177:00 amRNSNet Asset Value(s) - May 2017
21st Jun 20177:00 amRNSMonthly Update - May 2017
5th Jun 201712:48 pmRNSHolding(s) in Company - TR-1 Notification
2nd Jun 20172:15 pmRNSResult of Annual General Meeting
31st May 20174:00 pmRNSResults of Initial Placing
25th May 201712:15 pmRNSPublication of Prospectus and Placing
18th May 20177:00 amRNSNet Asset Value - 30 April 2017
18th May 20177:00 amRNSMonthly Update - April 2017
28th Apr 20175:00 pmRNSNotice of AGM
28th Apr 20175:00 pmRNSAGM and Financial Statement Notification
28th Apr 20177:30 amRNSDividend Declaration - Period to 31 March 2017
28th Apr 20177:00 amRNSAnnual Report and Financial Statements - Dec 2016
25th Apr 201711:23 amRNSMonthly Update - March 2017
25th Apr 20177:00 amRNSNet Asset Value - March 2017
21st Mar 20177:00 amRNSNet Asset Value - February 2017
21st Mar 20177:00 amRNSMonthly Update - February 2017
28th Feb 20179:30 amRNSTransfer of shareholding
28th Feb 20177:00 amRNSDividend Declaration - Period to 31 December 2016
21st Feb 20179:59 amRNSMonthly Update - January 2017
21st Feb 20179:58 amRNSNet Asset Value - January 2017
19th Jan 20172:49 pmRNSMonthly Update - December 2016
19th Jan 20172:12 pmRNSNet Asset Value - December 2016
21st Dec 20164:19 pmRNSMonthly Update - November 2016
20th Dec 20169:41 amRNSHolding(s) in Company - TR-1 Notification
20th Dec 20169:38 amRNSHolding(s) in Company - TR-1 Notification
19th Dec 201610:32 amRNSHolding(s) in Company - TR-1 Notification
16th Dec 20162:57 pmRNSPDMR Shareholding
14th Dec 20167:00 amRNSNet Asset Value - November 2016
12th Dec 20165:16 pmRNSIssue of Equity - Results of placing
9th Dec 201611:46 amRNSProposed Placing
1st Dec 201612:40 pmRNSPublication of a Supplementary Prospectus
18th Nov 20169:54 amRNSMonthly Update - October 2016
14th Nov 20162:55 pmRNSNet Asset Value(s) - October 2016
10th Nov 20165:20 pmRNSDividend Declaration-Period End 30 September 2016
25th Oct 201612:15 pmRNSNet Asset Value - Change to NAV calculation basis
14th Oct 20161:20 pmRNSNet Asset Value(s) - September 2016
30th Sep 20163:18 pmRNSMonthly Update - August 2016
14th Sep 20163:04 pmRNSNet Asset Value(s) - August 2016
30th Aug 20166:06 pmRNSHalf-year Report
26th Aug 20163:29 pmRNSHalf-year Report
26th Aug 20163:19 pmRNSDividend Declaration
25th Aug 20165:42 pmRNSMonthly Update - July 2016
12th Aug 20164:56 pmRNSNet Asset Value(s) - July 2016
15th Jul 20163:15 pmRNSNet Asset Value - June 2016 replacement of 3538E
15th Jul 20162:18 pmRNSPortfolio Update - June 2016

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.